Skip to main navigation Skip to search Skip to main content

APPRAISE-2 Apixaban for Prevention of Acute Ischhemic Safety Events

Project: Research

Project Details

StatusFinished
Effective start/end date04/16/09 → 04/15/11

Funding

  • Bristol Myers Squibb Company: $12,503.66